Internal MedicineJul 25, 2024|5 min readBy Adam Boros, PhDPfizer's next-generation therapies for inflammatory bowel diseaseJeremy Gale leads Pfizer’s inflammation & immunology research program to develop new therapies for moderate to severe inflammatory bowel disease.
